DEA Final Rule: Implementation Of The Substance Use Disorder Prevention That Promotes Opioid Recovery & Treatment For Patients & Communities Act Of 2018: Dispensing & Administering Controlled Substances For Medication-Assisted Treatment

The final rule was released on June 9, 2026 by the federal Drug Enforcement Administration (DEA). It goes into effect on July 9, 2026. The DEA formalized the end of the requirement that clinical professionals obtain an X-waiver to prescribe and dispense controlled substances as medications to treat opioid use disorder (MOUD), such as buprenorphine . . .